The US Department of Veterans Affairs (VA) is transforming cancer treatment for veterans by using 3D printing technology to produce FDA-cleared, patient-specific radiotherapy boluses (RTBs). Developed by the VA’s Office of Advanced Manufacturing (OAM), these custom-made boluses are designed to precisely target tumors while sparing healthy tissue, enhancing the effectiveness of radiation therapy for veterans.
Traditional boluses are often challenging to apply, requiring meticulous effort to ensure a flat, air pocket-free surface on the patient’s skin. VA’s 3D printed boluses eliminate these complications by utilizing a patient’s CT scan to create a personalized, perfectly fitting device. The result is improved accuracy, efficiency, and better treatment outcomes.
In collaboration with radiation oncology clinicians and 3D Systems, VA engineers at the Puget Sound VA facility in Seattle have produced 21 customized RTBs since April 2023, with clinicians reporting impressive results. This innovative solution aligns with the VA’s commitment to offering timely, precise, and effective cancer care to veterans, while expanding access to advanced treatments under the PACT Act.
With 41 radiation oncology sites across the country, the VA is rapidly expanding the availability of RTBs, further ensuring veterans receive the highest quality care.
